Filing Flows › Dare Bioscience (DARE) › Q2 2026 › vs Q1 2026
Dare Bioscience (DARE) Q2 2026 vs Q1 2026 (quarter over quarter)
Dare Bioscience's revenue rose $35K (+23%) from $152K in Q1 2026 to $188K in Q2 2026.
Dare Bioscience, Q2 2026: revenue $188K, net loss $3.0M, operating cash flow −$6.8M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $188K | $152K | $35K | +23% |
| Net loss | $3.0M | $3.0M | −$17K | -0.6% |
| Costs & expenses | $3.2M | $3.2M | $18K | +0.6% |
| Operating costs | $3.2M | $3.2M | $4K | +0.1% |
| Interest & other, net | $15K | $1K | $14K | 15× |
| Cost of revenue | $320K | $242K | $78K | +32% |
| Research & development | $242K | $660K | −$418K | -63% |
| SG&A | $2.6M | $2.2M | $345K | +15% |
| Operating cash sources | $7.6M | $6.5M | $1.1M | +17% |
| Depreciation & amortization | $572K | $555K | $18K | +3% |
| Share-based compensation | $287K | $455K | −$168K | -37% |
| Cash used in operations | $6.8M | $5.5M | $1.3M | +23% |
| Net loss absorbed | $3.0M | $3.0M | −$17K | -0.6% |
| Working capital & other | $4.7M | $3.5M | $1.1M | +32% |
Questions
How much did Dare Bioscience's revenue grow quarter over quarter in Q2 2026?
Dare Bioscience's revenue rose $35K (+23%) from $152K in Q1 2026 to $188K in Q2 2026.